Sign In
Buy NVO
$47.64
+0.230 (+0.485%)
At Close: Jun 25, 2026
Novo Nordisk (NVO) Outperforms Broader Market: What You Need to Know
06:50pm, Monday, 28'th Apr 2025
Novo Nordisk (NVO) closed at $62.62 in the latest trading session, marking a +0.87% move from the prior day.
S&P 500 (VOO) Live: Alphabet Up, Market Down But Improving Already
07:00am, Monday, 28'th Apr 2025
Live Updates Live Coverage Has Ended All's Well That Ends Green 4:30 pm All three major market indices ended in the green Friday. The Dow Jones Industrial Average closed up a bare 0.05%, while th
Novo Nordisk's obesity drug Wegovy debuts in Thailand
05:05am, Monday, 28'th Apr 2025
Novo Nordisk has launched its hugely popular weight-loss drug Wegovy in Thailand, an executive of the Danish drugmaker's local subsidiary said on Monday, marking the injectable drug's first entry into
How Eli Lilly and Novo Nordisk have separated themselves from their rivals
09:28pm, Friday, 25'th Apr 2025
Most companies are likely going to feel the impact of President Trump's tariffs. In the video above, BofA Securities senior pharma & biotech analyst Tim Anderson describes how tariffs will impact the
Why Novo Nordisk Stock Dropped Today
10:58am, Friday, 25'th Apr 2025
Novo Nordisk (NVO -1.68%), the Danish drugmaker of GLP-1 weight loss drugs Ozempic and Wegovy, slipped 2% through 10:30 a.m. ET Friday after suffering a one-two punch from Reuters and a bank analyst.
Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic
10:07am, Friday, 25'th Apr 2025
Novo Nordisk scored a huge legal victory that largely restricts compounding pharmacies from marketing or selling cheaper, unapproved versions of the drugmaker's blockbuster weight loss drug Wegovy and
The Best Stock to Buy With Less Than $60 in the Market Sell-Off
06:03am, Friday, 25'th Apr 2025
Plenty of stocks with attractive businesses trade on the market for hundreds of dollars per share -- or more. However, it's possible to find excellent stocks that may become undervalued when either th
Ozempic copies restricted after US judge denies injunction
06:51pm, Thursday, 24'th Apr 2025
A U.S. judge on Thursday rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk's popular diabetes and weight-loss drugs Ozempic and Wegovy while a legal challenge over drug sh
Novo Nordisk Plunges 17% in a Month: Buy, Sell or Hold the Stock?
12:20pm, Thursday, 24'th Apr 2025
Despite the current downward trend, long-term investors may stay invested in NVO stock due to strong demand for its GLP-1 drugs.
Novo Nordisk's stellar Wegovy-fuelled run of hiking sales guidance could be ending
01:12am, Thursday, 24'th Apr 2025
Since launching its wildly popular weight-loss drug Wegovy in 2021, Novo Nordisk has raised its annual sales guidance several times a year.
Chart Master: Sell Morgan Stanley, buy Novo Nordisk?
06:29pm, Wednesday, 23'rd Apr 2025
Carter Worth, Worth Charting, talks technicals on Morgan Stanley and Novo Nordisk.
Novo Nordisk Investors Just Got Terrible News. Should You Sell the Stock?
05:50am, Wednesday, 23'rd Apr 2025
Denmark-based pharmaceutical giant Novo Nordisk (NVO 2.66%) has been struggling during the past year. Its financial results -- though strong by comparison to most of its peers -- haven't been as good
Why Novo Nordisk Stock Popped Today
12:17pm, Tuesday, 22'nd Apr 2025
Novo Nordisk (NVO 2.71%), the Danish drugmaker that's been riding high ever since it began putting out Ozempic and Wegovy GLP-1 injectables for treatment of diabetes and weight loss, got another shot
Eli Lilly, Vertex, AbbVie and More Pharma Stocks to Own as Tariffs Loom
11:13am, Tuesday, 22'nd Apr 2025
Trump's tariff policy is the latest uncertainty to plague the pharmaceutical sector.
Novo Nordisk: Be Greedy When Others Are Fearful
10:49am, Tuesday, 22'nd Apr 2025
Novo Nordisk is a high-quality biopharma company with a strong diabetes franchise and a booming obesity drug segment, making it an attractive growth play. Following a 50% drop from recent highs, NVO t
